Related Experiment Videos
Do meal replacement drinks have a role in diabetes management?
1Medizinische Klinik, Universitätsklinikum Ulm, Ulm, Germany.
Summary
Meal replacement diets are more effective for weight loss in obese patients with type-2 diabetes than conventional diets. This strategy offers a structured plan for improved weight management and dietary variety.
Area of Science:
- Nutrition Science
- Metabolic Health
- Diabetes Management
Background:
- Conventional dietary treatments for type-2 diabetes often show limited effectiveness for weight loss and maintenance.
- Obesity is a significant comorbidity in type-2 diabetes, complicating management and increasing health risks.
Purpose of the Study:
- To evaluate the effectiveness of a meal replacement strategy compared to conventional diets for weight loss in obese patients with type-2 diabetes.
- To assess the long-term impact of meal replacements on body weight in this patient population.
Main Methods:
- The study involved comparing a structured meal replacement plan (one to two commercial, calorie-controlled meals daily) with a conventional individualized diet plan.
- Weight loss was measured at various time points, including 12 weeks, 4 years, 6 months, and 12 months.
Main Results:
- Obese subjects on meal replacements lost significantly more weight (7.3% at 12 weeks, 8.4% at 4 years) than those on conventional diets (1.4% at 12 weeks, 3.2% at 4 years).
- In type-2 diabetes patients, meal replacements resulted in greater weight loss (5.24% at 6 months, 4.35% at 12 months) compared to individualized diets (2.85% at 6 months, 2.36% at 12 months).
Conclusions:
- Meal replacement strategies provide a structured and effective approach for weight loss and maintenance in obese patients with type-2 diabetes.
- This dietary intervention shows promise for improving metabolic health outcomes in this vulnerable patient group.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...